Evidence map›Paper›PMID 26689200›Full record

ArticlePloS one2015

Walking the Line: A Fibronectin Fiber-Guided Assay to Probe Early Steps of (Lymph)angiogenesis.

Maria Mitsi, Martin Michael Peter Schulz, Epameinondas Gousopoulos, Alexandra Michaela Ochsenbein, Michael Detmar, Viola Vogel

Abstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. TGFBIp mediates lymphatic sprouting in corneal lymphangiogenesis.Journal of cellular and molecular medicine · 2019
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maria MitsiLaboratory of Applied Mechanobiology, ETH Zurich, Zurich, Switzerland.
Martin Michael Peter SchulzInstitute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland.
Epameinondas GousopoulosInstitute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland.
Alexandra Michaela OchsenbeinInstitute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland.
Michael DetmarInstitute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland.
Viola VogelLaboratory of Applied Mechanobiology, ETH Zurich, Zurich, Switzerland.

Funding

VPF/VEGF IN NORMAL AND NEOPLASTIC SKIN ANGIOGENESISR01CA069184 · NCI · SWISS FEDERAL INST OF TECH (ETH ZURICH) · PI DETMAR, MICHAEL J. · 1996 to 2008
$1.6M
European Research Council 233157NCI NIH HHS CA69184NCI NIH HHS R01 CA069184
6 · The paper itself

Abstract

Angiogenesis and lymphangiogenesis are highly complex morphogenetic processes, central to many physiological and pathological conditions, including development, cancer metastasis, inflammation and wound healing. While it is described that extracellular matrix (ECM) fibers are involved in the spatiotemporal regulation of angiogenesis, current angiogenesis assays are not specifically designed to dissect and quantify the underlying molecular mechanisms of how the fibrillar nature of ECM regulates vessel sprouting. Even less is known about the role of the fibrillar ECM during the early stages of lymphangiogenesis. To address such questions, we introduced here an in vitro (lymph)angiogenesis assay, where we used microbeads coated with endothelial cells as simple sprouting sources and deposited them on single Fn fibers used as substrates to mimic fibrillar ECM. The fibers were deposited on a transparent substrate, suitable for live microscopic observation of the ensuing cell outgrowth events at the single cell level. Our proof-of-concept studies revealed that fibrillar Fn, compared to Fn-coated surfaces, provides far stronger sprouting and guidance cues to endothelial cells, independent of the tested mechanical strains of the Fn fibers. Additionally, we found that VEGF-A, but not VEGF-C, stimulates the collective outgrowth of lymphatic endothelial cells (LEC), while the collective outgrowth of blood vascular endothelial cells (HUVEC) was prominent even in the absence of these angiogenic factors. In addition to the findings presented here, the modularity of our assay allows for the use of different ECM or synthetic fibers as substrates, as well as of other cell types, thus expanding the range of applications in vascular biology and beyond.

Indexed as

Endothelial CellsExtracellular MatrixFibronectinsHumansHuman Umbilical Vein Endothelial CellsLymphangiogenesisVascular Endothelial Growth Factor AVascular Endothelial Growth Factor CFibronectinsVascular Endothelial Growth Factor AVascular Endothelial Growth Factor CVEGFA protein, humanVEGFC protein, human

Identifiers

PMID26689200
PMCPMC4686943

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.